VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,431 | -49.6% | 793 | +31.9% | 0.00% | 0.0% |
| Q2 2023 | $14,743 | -67.6% | 601 | -69.3% | 0.00% | -80.0% |
| Q1 2023 | $45,563 | +224.4% | 1,958 | +252.8% | 0.01% | +150.0% |
| Q4 2022 | $14,047 | -26.1% | 555 | -42.8% | 0.00% | -33.3% |
| Q3 2022 | $19,000 | +90.0% | 970 | +145.6% | 0.00% | +200.0% |
| Q2 2022 | $10,000 | +400.0% | 395 | +456.3% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 71 | +115.2% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 33 | -52.2% | 0.00% | – |
| Q3 2021 | $3,000 | – | 69 | +1280.0% | 0.00% | – |
| Q2 2021 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |